ArticleJournal of nanobiotechnology2026
Honeycomb-inspired porous biomimetic scaffold with specific adaptability to host cells behavior for bone repair.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
In the field of bone defect repair, the three-dimensional architecture and bioactivity of tissue-engineered bone scaffolds play a pivotal role. However, two major challenges remain: the cell type–specific response of host cells to scaffold pore architecture and the sustained promotion of angiogenesis and osteogenesis essential for large-segment bone regeneration. Inspired by the structural characteristics of natural honeycombs, this study integrates 3D printing with hydrogel engineering to construct a novel composite scaffold. Its macro-level innovation lies in a multilevel pore structure, while its functional core stems from a meticulously designed “nano-bio interface”: layered double hydroxides (LDHs) loaded with deferoxamine (DFO) are assembled into nanosheets (DFO@LDHs) as key functional units, and are simultaneously integrated into both a polycaprolactone (PCL) framework (D@LP) and a glycidyl methacrylate-modified hyaluronic acid (HA-GMA) hydrogel (D@LG) to form the final composite scaffold (D@LG/D@LP). This nano-bio interface not only enables sustained, controlled release of bioactive factors but also actively regulates cellular spatiotemporal behavior. The unique pore distribution and degradation characteristics of the hydrogel and 3D-printed scaffold preferentially guide endothelial cell adhesion and microvascular network formation, subsequently initiating stem cell differentiation and bone matrix deposition. Both in vitro and in vivo experiments confirm the scaffold’s excellent biocompatibility. Through a nanomaterial-driven cascade regulation mechanism, it coordinates the activation of angiogenesis and osteogenesis, significantly accelerating vascularized bone regeneration. This work demonstrates an effective strategy for empowering three-dimensional scaffolds through nano-bio interface construction, achieving spatiotemporal programming for complex tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.